Fight Brewing In Congress Over Part D Coverage Gap Discounts

The fight over the Affordable Care Act and the repeal and replace of Obamacare concept.In American politics US parties are represented by either the democrat donkey or republican elephant

Biopharma is mobilizing support in Congress for rolling back the new law increasing the discounts required for branded drugs provided to Medicare Part D beneficiaries in the coverage gap from 50% to 70% beginning in 2019.

The discount surprised many in industry when news that it was part of a budget deal being worked out in...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Pricing Debate

More from Market Access